UPMC physicians Don Yealy, MD, Rob Bart, MD, and Rachel Sackrowitz, MD, played pivotal roles in developing a state-of-the-art #teleconsult technology platform at UPMC. This platform empowers clinician specialists to efficiently consult with bedside clinicians across various disciplines, including stroke, neurology, critical care, psychology, and toxicology. To date, it has facilitated 40,000 consults and significantly reduced patient wait times by 92%. Recently, eVisit acquired this technology from UPMC Enterprises, aiming to bolster the company’s #telehealth capabilities. Congratulations on an incredible accomplishment for the entire UPMC organization. https://lnkd.in/gNpJeyiD
UPMC’s Post
More Relevant Posts
-
CEO and Co-Founder Revive Medical Technologies Inc. Prof. Dr. Murtaza Najabat Ali (CEng (UK) FIMechE PE) met Mr. Mike Ryan Co-founder of NeuroSonic in USA, where they discussed about potential to collaborate where Revive Medical Technologies Inc. can provide R&D and regulatory services for the telestroke devices and related technologies for early detection of stroke. NeuroSonic aims to revolutionize stroke healthcare by developing a remote stroke risk monitoring device that uses machine learning to monitor stroke risk and overall cardiovascular health. Their goal is to empower convenient at-home monitoring, providing timely information and intervention to promote longevity. This potential collaboration highlights a major advancement in using cutting-edge technology to improve stroke care. With NeuroSonic's state-of-the-art inventions and Revive Medical Technologies Inc.'s research and development expertise, the partnership hopes to produce groundbreaking instruments that can enhance early diagnosis and treatment outcomes for stroke patients. #ReviveMedicalTechnologies #neurosonic #StrokeCare #telestrok #HealthcareInnovation #medicaltechnology #strokeprevention #earlydiagnosissaveslives #machinelearning #cardiovascularhealth #HealthcareCollaboration #remotemonitoring #patientcare
-
-
💙 Teamwork and collaboration 💙 makes work not only more FUN but it allows me to continue to develop from our talented team! Dominic Bailey I have already learnt so much from you on how clinical research can drive value for Nevro and how we free more patients from the burden of chronic pain! #NevroAUS #TeamWork #ClinicalResearch #DrivingOutcomes
🔬Nevro is dedicated to pioneering therapy innovation and driving patient access 💪 We deliver this through collaboration with physicians across Australia and the globe. Dominic Bailey, Clinical Research Manager for Nevro Australia, leads and coordinates multiple studies including feasibility for new technology and investigational studies into new indications. With over 12 years of experience designing and managing over 100 clinical trials, he provides a scientific, clinical, and business-orientated approach to the support of our clinical research partners to deliver contemporary evidence. Want to learn more about Nevro Clinical Research? Email [email protected] #NevroHFX #NevroAUS #Neuromodulation #ClinicalResearch #NevroHFXoutcomes
-
-
The Food and Drug Administration (FDA) has granted De Novo approval for BrainSee, a software platform that may predict up to a five-year progression of amnestic mild cognitive impairment (aMCI) to Alzheimer’s dementia, based on a combined artificial intelligence (AI) assessment of brain MRI and cognitive assessments. Through the aforementioned combination, BrainSee generates an automated score that notes the likelihood of progression from aMCI to Alzheimer’s dementia, according to Darmiyan, Inc., the developer of the software platform. Darmiyan emphasized that for patients with aMCI deemed to be at high risk for developing Alzheimer’s dementia within five years, the predictive screening capability afforded by BrainSee may facilitate personalized treatment. For those deemed to be at lower risk of Alzheimer’s dementia progression, the non-invasive BrainSee risk stratification may decrease patient anxiety as well as costs of more invasive tests, according to Darmiyan. "Our vision is to redefine brain health screening and monitoring standards and impact the lives of patients and their family members in a meaningful way,” noted Padideh Kamali-Zare, Ph.D., the founder and CEO of Darmiyan. “BrainSee is the first product of this vision, backed by our solid technological infrastructure that is capable of driving further transformations and scalable innovations in the brain health landscape.” An MRI can help save lives! ☎️ 954-905-7217 #floridakeys #plantation #floridalife #tampa #radiology #radiologist #radiographer #imaging #imagingcenter #medicalimaging #alzheimer #Dementia #medicalresearch #innovation #brainmri
-
-
An MRI can help save lives!
The Food and Drug Administration (FDA) has granted De Novo approval for BrainSee, a software platform that may predict up to a five-year progression of amnestic mild cognitive impairment (aMCI) to Alzheimer’s dementia, based on a combined artificial intelligence (AI) assessment of brain MRI and cognitive assessments. Through the aforementioned combination, BrainSee generates an automated score that notes the likelihood of progression from aMCI to Alzheimer’s dementia, according to Darmiyan, Inc., the developer of the software platform. Darmiyan emphasized that for patients with aMCI deemed to be at high risk for developing Alzheimer’s dementia within five years, the predictive screening capability afforded by BrainSee may facilitate personalized treatment. For those deemed to be at lower risk of Alzheimer’s dementia progression, the non-invasive BrainSee risk stratification may decrease patient anxiety as well as costs of more invasive tests, according to Darmiyan. "Our vision is to redefine brain health screening and monitoring standards and impact the lives of patients and their family members in a meaningful way,” noted Padideh Kamali-Zare, Ph.D., the founder and CEO of Darmiyan. “BrainSee is the first product of this vision, backed by our solid technological infrastructure that is capable of driving further transformations and scalable innovations in the brain health landscape.” An MRI can help save lives! ☎️ 954-905-7217 #floridakeys #plantation #floridalife #tampa #radiology #radiologist #radiographer #imaging #imagingcenter #medicalimaging #alzheimer #Dementia #medicalresearch #innovation #brainmri
-
-
Created for neurologists, neurosurgeons, engineers, regulatory professionals and investors in the field of neurology, our upcoming webinar will guide you through the Regulatory and Preclinical considerations to follow while bringing Neurological Medical Devices to market. Only one week left to register! Secure your free spot now: https://hubs.la/Q0288TNv0 #medtech #neurological #regulatorystrategy #medicaldevice #webinar
-
🌎 Medinexo welcomes former US Surgeon General Dr. Jerome Adams to our team. In this interview the importance of diversity in clinical research is discussed.🌎 . . . . . #clinicalresearchtrials #clinicaltrailsusa #clinicaltrail #clinicalpharmacy #clinicalresearchjobs #bioinformatics #clinicalresearchtrials #clinicalresearchers #clinicalresearchstudy #clinicalresearchcareers #clinicalresearchtraining #clinicalresearcher #clinicalresearchassociates #clinicalresearchwebinars #clinicalresearchprofessionals #Clinicalresearchassociate #clinicaltrialsguru #clinicalresearchcoordinator
-
Several factors are driving the global #𝐧𝐞𝐫𝐯𝐞_𝐫𝐞𝐩𝐚𝐢𝐫_𝐚𝐧𝐝_𝐫𝐞𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧_𝐦𝐚𝐫𝐤𝐞𝐭, such as the wide incidence of #nerve_injuries, the increasing prevalence of neurological disorders, and the growing government funding for research into #neurologic_disorders. 🌐𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲: https://lnkd.in/dvQaDfFG ▶ 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: ✔ Stryker ✔ NeuroPace Inc. ✔ LivaNova ✔ Boston Scientific ✔ axogen Corporation ✔ Neuronetics, Inc. ✔ Medtronic ✔ Integra LifeSciences, ✔ Baxter International Inc., ✔ Abbott, ✔ Regenity Biosciences (Formerly Polyganics), ✔ St. Jude Medical, ✔ LivaNova, ✔ Soterix Medical, ✔ Nevro, ✔ KERIMEDICAL SA, ✔ BioWave Corporation, ✔ Neuronetics, Inc., ✔ Synapse Biomedical, and other prominent players. 📣 𝐌𝐚𝐫𝐤𝐞𝐭 𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭: The market has prominent demand for neurostimulation and #neuromodulation_devices. It is further classified into internal neurostimulation and neuromodulation devices, external neurostimulation and neuromodulation devices, and biomaterials. #BlueWeave #marketresearch #healthcareindustry #medicalequipment #healthcaretechnology
-
-
I am delighted to share the publication of my article in the Bombay Times, delving into the indispensable role of vascular and interventional radiologists in modern-day medicine. Dive into the insights on how the specialists are shaping the future of healthcare. #InterventionalRadiology #ModernMedicine #vascularhealth #endovascularclinic #interventionaloncology #news #article #thebombaytimes
-
-
ICYMI, here's a link to our latest newsletter with updates on advocacy, leadership, #radres research, and a pull-no-punches Town Hall on the marital status of diagnostic and interventional #radiology: https://loom.ly/ROFsorM
IR-DR Town Hall, New COO, Advocacy Update
mailchi.mp
